Company overview
Evotec SE is a global drug discovery and development company headquartered in Hamburg, Germany, offering integrated solutions from target-to-clinic, including small molecules, biologics, and cell therapies. They provide expertise in proteomics, metabolomics, chemical biology, and biomarker discovery through sites like Munich. Evotec also supports drug substance manufacturing via Evotec DS in Germany and biologics development through Just – Evotec Biologics.
Pioneering Drug Discovery is listed in the NovaPharmaNews Supplier Hub as a CDMO & Manufacturing partner serving United States & Americas. Core focus areas include evotec, drug discovery, proteomics, biologics manufacturing, small molecule development.
Industry categories: CDMO & Manufacturing. These tags help R&D, manufacturing, and procurement teams discover vendors aligned with their pipeline stage and compliance requirements.
Structured facts
- Website
- https://www.evotec.com
- Categories
- CDMO & Manufacturing
- Markets served
- United States & Americas
- Keywords
- evotec, drug discovery, proteomics, biologics manufacturing, small molecule development
Products & technologies
Therapeutic areas
Markets served
Industry categories
Company timeline
- — Profile published on NovaPharmaNews
- — Profile last updated
Related suppliers in category
Frequently asked questions
- What drug discovery capabilities does Evotec offer?
- Evotec provides stand-alone and integrated drug discovery solutions covering target-to-clinic, including chemical biology, proteomics, metabolomics, bioinformatics, and modalities from small molecules to biotherapeutics.
- Where are Evotec's main locations and operations?
- Headquartered in Hamburg, Germany, with key sites in Munich (proteomics center), Neuried, and Halle/Westphalia for drug substance manufacturing; operates 13 sites in Europe and USA with over 3,100 employees worldwide.
- Does Evotec offer manufacturing services for pharma?
- Yes, through Evotec DS (acquired from Central Glass Germany) for clinical and commercial small molecule drug substance manufacturing, and Just – Evotec Biologics for biologics design, development, and manufacturing.
Related editorial coverage
- Drug Discovery USA 2026: What to Expect
- Lunai Bioworks and BrainStorm Therapeutics Launch AI Collaboration for Parkinson's and Rare Epilepsy
- Verge Rebrands AI Drug Discovery After Trial Setback
- Streamlined R&D at Novo Nordisk: Insights from Research Chief Petersen
- BBSW AI Solution Event: Daily Roundup
- BBSW AI Solution Event: Biotech Innovation in US
Explore lab tools and QA/QC resources for R&D teams.
